RxDoctor Payments Data

John Rolston

Neurological Surgery · Boston, MANPI 1871892091

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,231 of the $47,814 with a category attached, or 73.7%. 12 manufacturers reported payments, led by Neuropace, Inc. at 37.8% of the total.

$47,814in general payments, 2019–2025

Across 103 payments — averaging $464.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuropace, Inc.$18K
  • Medtronic$10K
  • Clearpoint Neuro, Inc.$9K
  • Turing Medical Technologies$7K
  • Insightec,inc$1K
  • Zimmer Biomet$742
  • plus $2K from 6 others
$79,090in research payments, 2019–2025

Across 15 payments — averaging $5272.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurocrine Biosciences, Inc.$40K
  • Insightec,ltd$26K
  • Medtronic$12K

What the payments were for

  • Consulting fees$35,23174%
  • Travel & lodging$7,22615%
  • Food & beverage$5,35611%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neuropace, Inc.33$18,082
Medtronic(3 entities)25$9,810
Clearpoint Neuro, Inc.15$9,014
Turing Medical Technologies2$7,125
Insightec,inc3$1,224
Zimmer Biomet7$742
Boston Scientific8$668
Abbott6$465
Vertex1$442
Teva Pharmaceuticals USA, Inc.1$86
Neurocrine Biosciences, Inc.1$83
Livanova USA, Inc.1$73

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,814 in reported general payments places this provider in the 85th percentile of 183 neurological surgery providers in Massachusetts.

See all neurological surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$79,099
Medicare patients
66
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →